Gazerani P
Curr Pain Headache Rep. 2025; 29(1):57.
PMID: 40029442
PMC: 11876209.
DOI: 10.1007/s11916-025-01366-3.
Sic A, Bogicevic M, Brezic N, Nemr C, Knezevic N
Biomedicines. 2025; 13(2).
PMID: 40002876
PMC: 11852498.
DOI: 10.3390/biomedicines13020463.
Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G
J Headache Pain. 2024; 25(1):189.
PMID: 39482575
PMC: 11529271.
DOI: 10.1186/s10194-024-01889-x.
Marelli A, Grazzi L, Visco M, Crescenzo P, Bavagnoli A, Sirotich C
Healthcare (Basel). 2024; 12(13).
PMID: 38998837
PMC: 11241822.
DOI: 10.3390/healthcare12131302.
Fedeli D, Ciullo G, Demichelis G, Medina Carrion J, Bruzzone M, Ciusani E
J Headache Pain. 2024; 25(1):97.
PMID: 38858629
PMC: 11165872.
DOI: 10.1186/s10194-024-01803-5.
Multimodal digital health treatments for Chronic Migraine associated with Medication Overuse Headache: a literature appraisal and results of a single-arm open trial (the BE-HOME program).
Grazzi L, Montisano D, DAmico D, Altamura C, Raggi A, Rizzoli P
Neurol Sci. 2024; 45(10):4923-4930.
PMID: 38771524
DOI: 10.1007/s10072-024-07568-8.
Effects of Dry Needling on Active Myofascial Trigger Points and Pain Intensity in Tension-Type Headache: A Randomized Controlled Study.
Monti-Ballano S, Marquez-Gonzalvo S, Lucha-Lopez M, Ferrandez-Laliena L, Vicente-Pina L, Sanchez-Rodriguez R
J Pers Med. 2024; 14(4).
PMID: 38672959
PMC: 11051369.
DOI: 10.3390/jpm14040332.
The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders.
Leonardi M, Martelletti P, Burstein R, Fornari A, Grazzi L, Guekht A
J Headache Pain. 2024; 25(1):4.
PMID: 38178049
PMC: 10768290.
DOI: 10.1186/s10194-023-01700-3.
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030.
Martelletti P, Leonardi M, Ashina M, Burstein R, Cho S, Charway-Felli A
J Headache Pain. 2023; 24(1):140.
PMID: 37884869
PMC: 10604921.
DOI: 10.1186/s10194-023-01666-2.
Do Electrical Stimulation Devices Reduce Pain and Improve Function?-A Comparative Review.
Allen C, Williamson T, Norwood S, Gupta A
Pain Ther. 2023; 12(6):1339-1354.
PMID: 37751060
PMC: 10616008.
DOI: 10.1007/s40122-023-00554-6.
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review.
Blumenfeld A, Lipton R, Silberstein S, Tepper S, Charleston 4th L, Landy S
Neurol Ther. 2023; 12(5):1533-1551.
PMID: 37542624
PMC: 10444724.
DOI: 10.1007/s40120-023-00529-x.
Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study).
Grazzi L, DAmico D, Guastafierro E, Demichelis G, Erbetta A, Fedeli D
J Headache Pain. 2023; 24(1):86.
PMID: 37452281
PMC: 10347788.
DOI: 10.1186/s10194-023-01630-0.
The Be-Home Kids Program: An Integrated Approach for Delivering Behavioral Therapies to Adolescents with Episodic and Chronic Migraine.
Grazzi L, Montisano D, Raggi A, Rizzoli P
Brain Sci. 2023; 13(4).
PMID: 37190664
PMC: 10136951.
DOI: 10.3390/brainsci13040699.
A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role.
Grazzi L, Montisano D, Rizzoli P, Guastafierro E, Marcassoli A, Fornari A
Toxins (Basel). 2023; 15(2).
PMID: 36828401
PMC: 9967692.
DOI: 10.3390/toxins15020086.
A Preliminary Analysis on the Feasibility and Short-Term Efficacy of a Phase-III RCT on Mindfulness Added to Treatment as Usual for Patients with Chronic Migraine and Medication Overuse Headache.
Grazzi L, Raggi A, Guastafierro E, Passavanti M, Marcassoli A, Montisano D
Int J Environ Res Public Health. 2022; 19(21).
PMID: 36360996
PMC: 9653620.
DOI: 10.3390/ijerph192114116.
Applying a biopsychosocial model to migraine: rationale and clinical implications.
Rosignoli C, Ornello R, Onofri A, Caponnetto V, Grazzi L, Raggi A
J Headache Pain. 2022; 23(1):100.
PMID: 35953769
PMC: 9367111.
DOI: 10.1186/s10194-022-01471-3.
Editorial: Artificial intelligence in brain-computer interfaces and neuroimaging for neuromodulation and neurofeedback.
Ponce H, Martinez-Villasenor L, Chen Y
Front Neurosci. 2022; 16:974269.
PMID: 35911982
PMC: 9336526.
DOI: 10.3389/fnins.2022.974269.
From the New Diagnostic Criteria to COVID-19 Pandemic Passing Through the Placebo Effect. What Have We Learned in the Management of Pediatric Migrane Over the Past 5 Years?.
Papetti L, Tarantino S, Ursitti F, Moavero R, Checchi Proietti M, Sforza G
Front Neurol. 2022; 13:935803.
PMID: 35911893
PMC: 9326104.
DOI: 10.3389/fneur.2022.935803.
Addressing the cost of chronic and episodic migraine and its main drivers: a short-term longitudinal analysis from a third-level Italian center.
Raggi A, Grazzi L, Guastafierro E, Marcassoli A, Passavanti M, Montisano D
Neurol Sci. 2022; 43(9):5717-5724.
PMID: 35618934
DOI: 10.1007/s10072-022-06164-y.
Effect of a Mindfulness-Based Intervention for Chronic Migraine and High Frequency Episodic Migraine in Adolescents: A Pilot Single-Arm Open-Label Study.
Grazzi L, Grignani E, Raggi A, Rizzoli P, Guastafierro E
Int J Environ Res Public Health. 2021; 18(22).
PMID: 34831494
PMC: 8619568.
DOI: 10.3390/ijerph182211739.